LBF20207PG01: Difference between revisions

No edit summary
No edit summary
Line 9: Line 9:
|Common Name=&&PROSTAGLANDIN A_1&&7- [ 2 (R) - (3 (S) -Hydroxy-1 (E) -octenyl) -5-oxo-3-cyclopenten-1 (R) -yl ] heptanoic acid&&(8R,12S,13E,15S) -15-Hydroxy-9-oxo-10,13-prostadienoic acid&&
|Common Name=&&PROSTAGLANDIN A_1&&7- [ 2 (R) - (3 (S) -Hydroxy-1 (E) -octenyl) -5-oxo-3-cyclopenten-1 (R) -yl ] heptanoic acid&&(8R,12S,13E,15S) -15-Hydroxy-9-oxo-10,13-prostadienoic acid&&
|Melting Point=42-44°C [[Reference:Pike_J_E:Lincoln_FH:Schneider_WP:,J. Org. Chem.,1969,34,3552|{{RelationTable/GetFirstAuthor|Reference:Pike_J_E:Lincoln_FH:Schneider_WP:,J. Org. Chem.,1969,34,3552}}]]
|Melting Point=42-44°C [[Reference:Pike_J_E:Lincoln_FH:Schneider_WP:,J. Org. Chem.,1969,34,3552|{{RelationTable/GetFirstAuthor|Reference:Pike_J_E:Lincoln_FH:Schneider_WP:,J. Org. Chem.,1969,34,3552}}]]
|Reflactive=ORD (H<SUB><FONT SIZE=-1>2</FONT></SUB>O, C=0.0040g/ml) : 256(+35.000°), 220(-43.000°) [[Reference:Andersen_NH:,J. Lipid Res.,1969,10,320|{{RelationTable/GetFirstAuthor|Reference:Andersen_NH:,J. Lipid Res.,1969,10,320}}]]
|Optical=ORD (H<SUB><FONT SIZE=-1>2</FONT></SUB>O, C=0.0040g/ml) : 256(+35.000°), 220(-43.000°) [[Reference:Andersen_NH:,J. Lipid Res.,1969,10,320|{{RelationTable/GetFirstAuthor|Reference:Andersen_NH:,J. Lipid Res.,1969,10,320}}]]
|Solubility=ETHANOL, CHLOROFORM [[Reference:Pike_J_E:Lincoln_FH:Schneider_WP:,J. Org. Chem.,1969,34,3552|{{RelationTable/GetFirstAuthor|Reference:Pike_J_E:Lincoln_FH:Schneider_WP:,J. Org. Chem.,1969,34,3552}}]], METHANOL [[Reference:Andersen_NH:,J. Lipid Res.,1969,10,320|{{RelationTable/GetFirstAuthor|Reference:Andersen_NH:,J. Lipid Res.,1969,10,320}}]]
|Solubility=ETHANOL, CHLOROFORM [[Reference:Pike_J_E:Lincoln_FH:Schneider_WP:,J. Org. Chem.,1969,34,3552|{{RelationTable/GetFirstAuthor|Reference:Pike_J_E:Lincoln_FH:Schneider_WP:,J. Org. Chem.,1969,34,3552}}]], METHANOL [[Reference:Andersen_NH:,J. Lipid Res.,1969,10,320|{{RelationTable/GetFirstAuthor|Reference:Andersen_NH:,J. Lipid Res.,1969,10,320}}]]
|Mass Spectra=m/e, 336(M<SUP><FONT SIZE=-1>+</FONT></SUP>), 318(M-18), 300(M-36), 265(M-71), 247, 219, 190 [[Reference:Pike_J_E:Lincoln_FH:Schneider_WP:,J. Org. Chem.,1969,34,3552|{{RelationTable/GetFirstAuthor|Reference:Pike_J_E:Lincoln_FH:Schneider_WP:,J. Org. Chem.,1969,34,3552}}]]
|Mass Spectra=m/e, 336(M<SUP><FONT SIZE=-1>+</FONT></SUP>), 318(M-18), 300(M-36), 265(M-71), 247, 219, 190 [[Reference:Pike_J_E:Lincoln_FH:Schneider_WP:,J. Org. Chem.,1969,34,3552|{{RelationTable/GetFirstAuthor|Reference:Pike_J_E:Lincoln_FH:Schneider_WP:,J. Org. Chem.,1969,34,3552}}]]
Line 19: Line 19:
|Chemical Synthesis=[[Reference:Pike_J_E:Lincoln_FH:Schneider_WP:,J. Org. Chem.,1969,34,3552|{{RelationTable/GetFirstAuthor|Reference:Pike_J_E:Lincoln_FH:Schneider_WP:,J. Org. Chem.,1969,34,3552}}]] {{Image200|LBF20207PG01FT0001.gif}}
|Chemical Synthesis=[[Reference:Pike_J_E:Lincoln_FH:Schneider_WP:,J. Org. Chem.,1969,34,3552|{{RelationTable/GetFirstAuthor|Reference:Pike_J_E:Lincoln_FH:Schneider_WP:,J. Org. Chem.,1969,34,3552}}]] {{Image200|LBF20207PG01FT0001.gif}}
|Metabolism=
|Metabolism=
|Symbol=PGA1
|Biological Activity=Prostaglandin A1 relaxes uterine muscle and shows hypotensive effects on rat and dog [[Reference:Bergstrom_S:Carlson_LA:Weeks_JR:,Pharmacol. Rev.,1968,20,1|{{RelationTable/GetFirstAuthor|Reference:Bergstrom_S:Carlson_LA:Weeks_JR:,Pharmacol. Rev.,1968,20,1}}]].
|Other Spectra=ORD(H<SUB><FONT SIZE=-1>2</FONT></SUB>O, C=0.0040g/100ml), 256(+35, 000°), 220(-43,000°) [[Reference:Andersen_NH:,J. Lipid Res.,1969,10,320|{{RelationTable/GetFirstAuthor|Reference:Andersen_NH:,J. Lipid Res.,1969,10,320}}]]
}}
}}


{{Lipid/Footer}}
{{Lipid/Footer}}

Revision as of 21:00, 6 January 2010

LipidBank Top
(トップ) 		Fatty acid
(脂肪酸) 		Glycerolipid
(グリセロ脂質) 		Sphingolipid
(スフィンゴ脂質) 		Journals
(雑誌一覧) 		How to edit
(ページの書き方)


Upper classes: LB LBF



IDs and Links
LipidBank XPR1000
LipidMaps LMFA03010005
CAS
KEGG {{{KEGG}}}
KNApSAcK {{{KNApSAcK}}}
mol LBF20207PG01
PROSTAGLANDIN A1
LBF20207PG01.png
Structural Information
7- [ 2 (R) - (3 (S) -Hydroxy-1 (E) -octenyl) -5-oxo-3-cyclopenten-1 (R) -yl ] heptanoic acid / (8R,12S,13E,15S) -15-Hydroxy-9-oxo-10,13-prostadienoic acid
  • PROSTAGLANDIN A1
  • 7- [ 2 (R) - (3 (S) -Hydroxy-1 (E) -octenyl) -5-oxo-3-cyclopenten-1 (R) -yl ] heptanoic acid
  • (8R,12S,13E,15S) -15-Hydroxy-9-oxo-10,13-prostadienoic acid
 PGA1
Formula C20H32O4
Exact Mass 336.23005951199997
Average Mass 336.46567999999996
SMILES C(CC[C@@H](O)C=C[C@H]([C@H]1CCCCCCC(O)=O)C=CC(=O)1)CC
Physicochemical Information
42-44°C Pike_J_E et al.
ORD (H2O, C=0.0040g/ml) : 256(+35.000°), 220(-43.000°) Andersen_NH
ETHANOL, CHLOROFORM Pike_JEet al., METHANOL Andersen_NH
Prostaglandin A1 is found in human seminal plasma Bergstrom_S .
Pike_J_E et al.
LBF20207PG01FT0001.gif
Prostaglandin A1 relaxes uterine muscle and shows hypotensive effects on rat and dog Bergstrom_S et al..
Spectral Information
Mass Spectra m/e, 336(M+), 318(M-18), 300(M-36), 265(M-71), 247, 219, 190 Pike_JEet al.
UV Spectra l EtOHmax = 217nm(e 11,650) Pike_JEet al.
IR Spectra NUJOL : n 3420, 2740, 2700, 2660, 2600, 1715, 1700, 1585, 1275, 1200,1180, 1020, 720cm-1 Pike_JEet al.
NMR Spectra 1H-NMR(CDCl3, TMS) : d, 7.52(dd, 1H), 6.17(dd, 1H), 5.6(m, 2H), 4.1(m, 1H, 15-CH), 3.25(12H) Pike_JEet al.
Other Spectra ORD(H2O, C=0.0040g/100ml), 256(+35, 000°), 220(-43,000°) Andersen_NH
Chromatograms
Reported Metabolites, References
Biospecies ID Compound Name Reference Comment
n.a. LBF20207PG01 See above. Andersen_NH 1969
n.a. LBF20207PG01 See above. Bergstrom_S 1967
n.a. LBF20207PG01 See above. Bergstrom_S et al. 1968
n.a. LBF20207PG01 See above. Pike_JE et al. 1969


Retrieved from "http://lipidbank.jp/mediawiki/index.php?title=LBF20207PG01&oldid=52359"